Gene expression profiling to predict viridans group streptococcal and invasive fungal infection in pediatric acute myeloid leukemia: a brief report from the Children's Oncology Group.
Division of Infectious Diseases, The Children's Hospital of Philadelphia, Philadelphia, Pa., USA.
Grace E
GE
Lee
Lillian
L
Sung
Brian T
BT
Fisher
Kathleen E
KE
Sullivan
Tom
T
McWilliams
John W
JW
Tobias
Soheil
S
Meshinchi
Todd A
TA
Alonzo
Alan
A
Gamis
Richard
R
Aplenc
D000293:Adolescent; D000617:Aminoglycosides / Q000008:administration & dosage; D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage; D016022:Case-Control Studies; D002648:Child; D005260:Female; D000079982:Gemtuzumab; D020869:Gene Expression Profiling; D020022:Genetic Predisposition to Disease; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000150:complications* / Q000188:drug therapy / Q000235:genetics*; D008297:Male; D009181:Mycoses / Q000209:etiology* / Q000235:genetics; D010865:Pilot Projects; D013290:Streptococcal Infections / Q000209:etiology* / Q000235:genetics; D034363:Viridans Streptococci
D000617:Aminoglycosides; D061067:Antibodies, Monoclonal, Humanized; D000079982:Gemtuzumab